ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001) Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin converting enzyme inhibitors? A meta-analysis of individual patient data. Annals of Internal Medicine, 134, 370-379. doi:10.7326/0003-4819-134-5-200103060-00009

has been cited by the following article:

• TITLE: Absence of albuminuria in type 2 diabetics with classical diabetic nephropathy: Clinical pathological study

  AUTHORS: Pooja Budhiraja, Bijin Thajudeen, Mordecai Popovtzer

  KEYWORDS: Kimmelstiel-Wilson Lesions; Diabetes Mellitus; Nephropathy; Albuminuria

  JOURNAL NAME: Journal of Biomedical Science and Engineering, Vol.6 No.5A, May 28, 2013

  ABSTRACT: Background: Diabetic nephropathy is the most common cause of chronic kidney disease and the number afflicted patients continues to rise. The presence of proteinuria has been considered as a prerequisite for the diagnosis of diabetic nephropathy. But one third to one half of type 2 diabetics with CKD have no proteinuria and the pathology of non proteinuric CKD in this group remains unclear as renal biopsy is commonly not performed in these patients. The present study addresses the question: Can a classical diabetic nephropathy occur in the absence of proteinuria? Method: We examined renal biopsies of subjects who underwent nephrectomy from 1999 to 2009 for renal cancer, had eGFR